NewsCorporate ActionsNCLT Approves Amalgamation of Medinova Diagnostic Services with Vijaya Diagnostic CentreNCLT Approves Amalgamation of Medinova Diagnostic Services with Vijaya Diagnostic Centre
The NCLT Hyderabad Bench has sanctioned the amalgamation of Medinova Diagnostic Service with Vijaya Diagnostic Centre. The merger, effective from October 13, 2025, with an appointed date of April 1, 2024, involves a share exchange ratio of 1:22. Vijaya's current 62.14% stake in Medinova will be cancelled. The amalgamation aims to create synergies, reduce costs, and simplify the group structure in the diagnostic services sector. The NCLT has addressed regulatory concerns, including pending inquiries and MSME dues.
*this image is generated using AI for illustrative purposes only.
The National Company Law Tribunal (NCLT), Hyderabad Bench, has sanctioned the scheme of amalgamation between Medinova Diagnostic Service and Vijaya Diagnostic Centre Limited, marking a significant development in the diagnostic services sector.
Key Details of the Amalgamation
- Effective Date: The final order was pronounced on October 13, 2025
- Appointed Date: April 1, 2024
- Share Exchange Ratio: Shareholders of Medinova Diagnostic Service will receive 1 equity share of Vijaya for every 22 shares held
Impact on Shareholding
Vijaya Diagnostic Centre, which currently holds a 62.14% stake in Medinova Diagnostic Service, will see its shares in the transferor company cancelled as part of the amalgamation process. This move is expected to simplify the group structure and create operational synergies.
Business Operations
Both companies operate in the diagnostic services sector, offering:
- Pathological investigations
- Radiology services
- Nuclear medicine
Objectives of the Amalgamation
The merger aims to:
- Create synergies between the businesses
- Reduce operational costs
- Simplify the group structure
Regulatory Considerations
The NCLT has addressed various regulatory concerns, including:
- Pending inquiries against Medinova Diagnostic Service
- MSME dues
The transferee company has provided necessary undertakings for compliance with these matters.
Stock Exchange Listings
- Medinova Diagnostic Service shares are listed on BSE
- Vijaya trades on both BSE and NSE
Conclusion
This amalgamation represents a strategic move in the diagnostic services industry, potentially leading to a stronger, more efficient entity. Stakeholders will be watching closely to see how the combined company leverages its expanded capabilities and market presence in the coming months.
Historical Stock Returns for Medinova Diagnostic Service
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.94% | +4.87% | 0.0% | +4.87% | +3.83% | +193.40% |
17
